Karel Kostev to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Karel Kostev has written about Biosimilar Pharmaceuticals.
Connection Strength
0.611
-
Prevalence of switching from two anti-TNF biosimilars back to biologic reference products in Germany?. Int J Clin Pharmacol Ther. 2019 Jun; 57(6):323-328.
Score: 0.611
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.